Latest News for: arv

Edit

Future of local ARV production in doubt as State-owned pharmaceutical company stalls

Independent online (SA) 20 Feb 2026
Health Minister Aaron Motsoaledi has shed light on the government’s intentions concerning local manufacturing of ARV drugs ... The concerns were heightened following the business rescue of two major ARV ...
Edit

Concerns raised over R15 billion ARV tender as EFF calls for SIU investigation

Independent online (SA) 19 Feb 2026
The Economic Freedom Fighters (EFF) has expressed serious concern over the R15 billion antiretroviral (ARV) tender awarded by the Department of Health, calling for a full investigation into alleged irregularities in the procurement process.
Edit

Media Statement: Portfolio Committee on Health Concerned by Lack of Due Diligence in Awarding ARV Tenders (Parliament of South Africa)

Public Technologies 19 Feb 2026
During a briefing on Tuesday with the Minister of Health, Dr Aaron Motsoaledi, and the Department of Health, committee members dissected the tendering process that resulted in the placement of two ARV suppliers under business rescue.
Edit

Minister challenges committee to investigate ARV tender irregularities

Independent online (SA) 18 Feb 2026
Health Minister Aaron Motsoaledi challenged the Health Portfolio Committee on Wednesday to take a resolution that will recommend the Special Investigating Unit (SIU) to probe the ARV tender.
Edit

No patient impact: Motsoaledi's assurance on ARV supply continuity

Independent online (SA) 18 Feb 2026
Health Minister Aaron Motsoaledi said on Wednesday that no patient has been affected by the two ARV suppliers that are undergoing the business rescue process. Motsoaledi said the provinces have an adequate stock of ARVs to cover three months.
Edit

Media Alert: Committee on Health to Be Briefed on Arv Suppliers Under Business Rescue (Parliament of South Africa)

Public Technologies 17 Feb 2026
) Parliament, Tuesday, 17 February 2026 - The Portfolio Committee on Health will tomorrow be briefed by the Minister of Health, Dr Aaron Mostoaledi, on contingency measures following the placement of ARV suppliers under business rescue ... Date ... Time.
Edit

Media Alert: Committee on Health Briefed on ARV Suppliers That Are Under Business Rescue (Parliament of South Africa)

Public Technologies 04 Feb 2026
). Parliament, Wednesday, 4 February 2026 - The Portfolio Committee on Health will today be briefed by the Minister of Health, Dr Aaron Mostoaledi, on contingency measures following the placement of ARV suppliers under business rescue ... Date ... Time ... Venue.
Edit

«Кулак» фронтового разведчика: США оснащают новые бронемашины ARV башней RT20

Topwar 30 Jan 2026
Пентагон активно перевооружает морскую пехоту, готовя её к боям с серьёзным противником ....
Edit

Media Statement: Committee Chairperson Expresses Concern on ARV Suppliers Placed Under Business Rescue (Parliament of South Africa)

Public Technologies 27 Jan 2026
Ms Muthambi said, the media reports are worrying, particularly given the millions of AIDS patients who rely on ARVs medication ... The ARVs tender was deliberately awarded to multiple suppliers as a risk mitigation strategy.
Edit

DA demands urgent accountability after ARV suppliers placed in business rescue (DA - Democratic Alliance)

Public Technologies 27 Jan 2026
) DA demands urgent accountability after ARV suppliers placed in business rescue. Issued by Michele Clarke MP - DA Spokesperson on Health. 23 Jan 2026 in News ... The companies are subsidiaries of Avacare Health ... Attachments Original document Permalink.
Edit

Health department assures no ARV shortage despite supplier issues

Sowetan Live 25 Jan 2026
The health department has assured the public that South Africa is not facing a shortage of antiretroviral (ARV) medicines despite reports that two suppliers awarded contracts under the current ARV tender have entered business rescue.
Edit

Award-winning ARV pill aims to ease children’s medication struggles

Sowetan Live 05 Dec 2025
The children’s ARV project was conceived by Kotlolo and scientists at TUT and the University of Eastern Finland in collaboration with pharmaceutical company Kiara Health.
×